356 related articles for article (PubMed ID: 17522861)
1. Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.
Jordan JT; Sun W; Hussain SF; DeAngulo G; Prabhu SS; Heimberger AB
Cancer Immunol Immunother; 2008 Jan; 57(1):123-31. PubMed ID: 17522861
[TBL] [Abstract][Full Text] [Related]
2. CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells.
Chang AL; Miska J; Wainwright DA; Dey M; Rivetta CV; Yu D; Kanojia D; Pituch KC; Qiao J; Pytel P; Han Y; Wu M; Zhang L; Horbinski CM; Ahmed AU; Lesniak MS
Cancer Res; 2016 Oct; 76(19):5671-5682. PubMed ID: 27530322
[TBL] [Abstract][Full Text] [Related]
3. Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model.
Banissi C; Ghiringhelli F; Chen L; Carpentier AF
Cancer Immunol Immunother; 2009 Oct; 58(10):1627-34. PubMed ID: 19221744
[TBL] [Abstract][Full Text] [Related]
4. Local Application of Autologous Platelet-Rich Fibrin Patch (PRF-P) Suppresses Regulatory T Cell Recruitment in a Murine Glioma Model.
Panek WK; Pituch KC; Miska J; Kim JW; Rashidi A; Kanojia D; Lopez-Rosas A; Han Y; Yu D; Chang CL; Kane JR; Zhang P; Cordero A; Lesniak MS
Mol Neurobiol; 2019 Jul; 56(7):5032-5040. PubMed ID: 30460615
[TBL] [Abstract][Full Text] [Related]
5. Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2
Takacs GP; Kreiger CJ; Luo D; Tian G; Garcia JS; Deleyrolle LP; Mitchell DA; Harrison JK
Front Immunol; 2022; 13():993444. PubMed ID: 36685592
[TBL] [Abstract][Full Text] [Related]
6. Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors.
Wainwright DA; Chang AL; Dey M; Balyasnikova IV; Kim CK; Tobias A; Cheng Y; Kim JW; Qiao J; Zhang L; Han Y; Lesniak MS
Clin Cancer Res; 2014 Oct; 20(20):5290-301. PubMed ID: 24691018
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide-induced modification of the CXC chemokine network in experimental gliomas.
Bruyère C; Mijatovic T; Lonez C; Spiegl-Kreinecker S; Berger W; Kast RE; Ruysschaert JM; Kiss R; Lefranc F
Int J Oncol; 2011 May; 38(5):1453-64. PubMed ID: 21399866
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance and mechanism of Treg infiltration in human brain tumors.
Jacobs JF; Idema AJ; Bol KF; Grotenhuis JA; de Vries IJ; Wesseling P; Adema GJ
J Neuroimmunol; 2010 Aug; 225(1-2):195-9. PubMed ID: 20537408
[TBL] [Abstract][Full Text] [Related]
9. Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy.
Zhu X; Fujita M; Snyder LA; Okada H
J Neurooncol; 2011 Aug; 104(1):83-92. PubMed ID: 21116835
[TBL] [Abstract][Full Text] [Related]
10. Functional reprogramming of human prostate cancer to promote local attraction of effector CD8(+) T cells.
Muthuswamy R; Corman JM; Dahl K; Chatta GS; Kalinski P
Prostate; 2016 Sep; 76(12):1095-105. PubMed ID: 27199259
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu.
Wang XQ; Zhou WJ; Luo XZ; Tao Y; Li DJ
Hum Reprod; 2017 Jun; 32(6):1304-1317. PubMed ID: 28383711
[TBL] [Abstract][Full Text] [Related]
12. Circulating T regulatory cells migration and phenotype in glioblastoma patients: an in vitro study.
Vasco C; Canazza A; Rizzo A; Mossa A; Corsini E; Silvani A; Fariselli L; Salmaggi A; Ciusani E
J Neurooncol; 2013 Dec; 115(3):353-63. PubMed ID: 24005771
[TBL] [Abstract][Full Text] [Related]
13. NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment.
Mailloux AW; Young MR
J Immunol; 2009 Mar; 182(5):2753-65. PubMed ID: 19234170
[TBL] [Abstract][Full Text] [Related]
14. CCL2/CCR2 signaling pathway in glioblastoma multiforme.
Vakilian A; Khorramdelazad H; Heidari P; Sheikh Rezaei Z; Hassanshahi G
Neurochem Int; 2017 Feb; 103():1-7. PubMed ID: 28025034
[TBL] [Abstract][Full Text] [Related]
15. S100B promotes glioma growth through chemoattraction of myeloid-derived macrophages.
Wang H; Zhang L; Zhang IY; Chen X; Da Fonseca A; Wu S; Ren H; Badie S; Sadeghi S; Ouyang M; Warden CD; Badie B
Clin Cancer Res; 2013 Jul; 19(14):3764-75. PubMed ID: 23719262
[TBL] [Abstract][Full Text] [Related]
16. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V
J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169
[TBL] [Abstract][Full Text] [Related]
17. Specific recruitment of regulatory T cells into the CSF in lymphomatous and carcinomatous meningitis.
Haas J; Schopp L; Storch-Hagenlocher B; Fritzsching B; Jacobi C; Milkova L; Fritz B; Schwarz A; Suri-Payer E; Hensel M; Wildemann B
Blood; 2008 Jan; 111(2):761-6. PubMed ID: 17967942
[TBL] [Abstract][Full Text] [Related]
18. In vitro migration of cytotoxic T lymphocyte derived from a colon carcinoma patient is dependent on CCL2 and CCR2.
Berencsi K; Rani P; Zhang T; Gross L; Mastrangelo M; Meropol NJ; Herlyn D; Somasundaram R
J Transl Med; 2011 Mar; 9():33. PubMed ID: 21450101
[TBL] [Abstract][Full Text] [Related]
19. The role of regulatory T-cells in glioma immunology.
Ooi YC; Tran P; Ung N; Thill K; Trang A; Fong BM; Nagasawa DT; Lim M; Yang I
Clin Neurol Neurosurg; 2014 Apr; 119():125-32. PubMed ID: 24582432
[TBL] [Abstract][Full Text] [Related]
20. Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy.
Crane CA; Ahn BJ; Han SJ; Parsa AT
Neuro Oncol; 2012 May; 14(5):584-95. PubMed ID: 22406925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
